Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Radiesse® Dermal Filler for Hand Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Has right and left hands with rating of 2 or 3 on the Merz Hand Grading Scale (MHGS) as determined by a live, masked evaluator~* Is at least 18 years of age~Exclusion Criteria:~* Has history of hypertropic scarring~* Has a known bleeding disorder or receiving medication that will increase the risk of bleeding as the result of injection~* Has a known hypersensitivity to any of the components of Radiesse or local anesthesia~* Has received in past 6 months or plans to receive during the study dermal resurfacing procedure (chemical peel, dermabrasion, ablative laser resurfacing) or non-invasive skin tightening (Thermage®) in the dorsum of the hands~* Has received in past 2 weeks or plans to receive during the study prescription wrinkle therapies, topical steroids, skin irritating topical preparations, or pigmenting agents (self-tanning agents) in the dorsum of the hands~* Has had any dermal fillers or surgery in the dorsum of the hand

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Radiesse® Injectable Dermal Filler (Type: EXPERIMENTAL): Device: Radiesse Dermal Filler mixed with 2% lidocaine-HCl (final concentration: 0.3% lidocaine-HCl)
- Delayed Treatment (Type: ACTIVE_COMPARATOR): Untreated controls crossed over to treatment with Radiesse Dermal Filler mixed with 2% lidocaine-HCl (final concentration: 0.3% lidocaine) at 3 months

Based on this trial design, predict the completion outcome and termination type (if applicable).